People take NMN for its wider NMN anti ageing effects, such as energy support and recovery
The first genome-scale metabolic model (GSMM) iRV973 for Candida auris predicted growth under various nutrient conditions and identified 50 conserved, serum-essential enzymessome as novel, non-homologous drug targets (Viana et al., 2023)
391 While endocrine therapy remains pivotal in the treatment of HR+/HER2 breast cancer, previous research indicates that neoadjuvant endocrine therapy does not significantly enhance the pCR rate
New insights into ferroptosis initiating therapies (FIT) by targeting the rewired lipid metabolism in ovarian cancer peritoneal metastases
because rigorously controlled human safety data specific to the TB-500 fragment does not exist, its longer-term risk profile, including possible immune reactions, remains unknown Evidence snapshot: Evidence for TB-500 itself is preclinical, drawn mainly from cell-culture and animal studies (a 1999 rat wound-healing study and later rodent cardiac- and tendon-injury models), with a 2026 scoping review describing the musculoskeletal literature on thymosin beta-4 and TB-500 as sparse and largely preclinical
BPC-157 is listed on the World Anti-Doping Agency (WADA) prohibited list
